Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial.

World Allergy Organ J · 2023 · PMC10665923 · PMID 38020288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an observed trendno p-value reported

Although attack rates were also low in subgroup 2, there was an observed trend for higher attack rates compared to subgroup 1, which was reduced through 12 months of berotralstat treatment.

also in 504 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.